The Food and Drug Administration guidelines finalized Thursday ease decades-old restrictions designed to protect the blood supply from HIV.

A new poll found that a nationwide ban on the drug mifepristone is overwhelmingly unpopular — including among Republicans.

If the FDA approval for mifepristone is blocked, some abortion care providers across the country may have to stop offering medication abortion altogether.

An anti-abortion group is seeking to reverse the FDA’s approval of mifepristone, which could result in the pill being removed from the market across the country.

An estimated 48 million people in the United States have some form of hearing loss.

‘These updated boosters present us with an opportunity to get ahead’ of the next COVID-19 wave, said FDA Commissioner Dr. Robert Califf.

‘A lot of people are going to be happy and a lot of grandparents are going to be happy, too.’

‘We have waited a long time for this moment,’ White House COVID-19 coordinator Dr. Ashish Jha said.

The National Republican Congressional Committee released a campaign ad falsely blaming Democrats for the formula shortage.

President Joe Biden said, ‘We moved as quickly as the problem became apparent to us.’

‘Our goal here is to stay ahead of future variants and outbreaks and ensure we do our best to reduce the toll of disease and death due to COVID-19,’ said FDA vaccine chief Dr. Peter Marks.

The initial batch of test kits will be available starting next week, President Joe Biden said, when the administration launches a new website where Americans can request the free tests.

President Joe Biden said vaccine boosters would be released ‘pending approval’ from the FDA.

Officials are hoping that extending vaccinations to children will allow schools to reopen with minimal disruption this fall.

Clinics can continue to use telehealth practices to make patient care safer during the pandemic.

Observers noted that details about Donald Trump’s treatment could indicate that his condition was worrisome.  

Stephen Hahn’s comments on the use of plasma against the coronavirus drew condemnation from scientists and some former FDA officials.

The FDA has concluded the anti-malaria drug is ineffective against the coronavirus.